COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Cell. 2021 Apr 1;184(7):1895-1913.e19. doi: 10.1016/j.cell.2021.01.053. Epub 2021 Feb 3.

Abstract

A dysfunctional immune response in coronavirus disease 2019 (COVID-19) patients is a recurrent theme impacting symptoms and mortality, yet a detailed understanding of pertinent immune cells is not complete. We applied single-cell RNA sequencing to 284 samples from 196 COVID-19 patients and controls and created a comprehensive immune landscape with 1.46 million cells. The large dataset enabled us to identify that different peripheral immune subtype changes are associated with distinct clinical features, including age, sex, severity, and disease stages of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA was found in diverse epithelial and immune cell types, accompanied by dramatic transcriptomic changes within virus-positive cells. Systemic upregulation of S100A8/A9, mainly by megakaryocytes and monocytes in the peripheral blood, may contribute to the cytokine storms frequently observed in severe patients. Our data provide a rich resource for understanding the pathogenesis of and developing effective therapeutic strategies for COVID-19.

Keywords: B cell receptor sequencing; COVID-19; SARS-CoV-2; T cell receptor sequencing; cell-cell interaction; cytokine storm; host cell range; ligand-receptor interaction; single-cell RNA-seq; single-cell transcriptomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / immunology*
  • Child
  • China
  • Cohort Studies
  • Cytokines / metabolism
  • Female
  • Humans
  • Male
  • Megakaryocytes / immunology*
  • Middle Aged
  • Monocytes / immunology*
  • RNA, Viral* / blood
  • RNA, Viral* / isolation & purification
  • SARS-CoV-2 / genetics*
  • Single-Cell Analysis
  • Transcriptome / immunology
  • Young Adult

Substances

  • Cytokines
  • RNA, Viral